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Abstract
Background: Because to date there is no available study on STAT3 polymorphism and gastric cancer in Western
populations and taking into account that Helicobacter pylori CagA EPIYA-C segment deregulates SHP-2/ERK-JAK/
STAT3 pathways, we evaluated whether the two variables are independently associated with gastric cancer.
Methods: We included 1048 subjects: H. pylori-positive patients with gastric carcinoma (n = 232) and with gastritis
(n = 275) and 541 blood donors. Data were analyzed using logistic regression model.
Results: The rs744166 polymorphic G allele (p = 0.01; OR = 1.76; 95 % CI = 1.44-2.70), and CagA-positive (OR = 12.80;
95 % CI = 5.58-19.86) status were independently associated with gastric cancer in comparison with blood donors.
The rs744166 polymorphism (p = 0.001; OR = 1.64; 95 % CI = 1.16-2.31) and infection with H. pylori CagA-positive
strains possessing higher number of EPIYA-C segments (p = 0.001; OR = 2.28; 95 % CI = 1.41-3.68) were independently
associated with gastric cancer in comparison with gastritis. The association was stronger when host and bacterium
genotypes were combined (p < 0.001; OR = 3.01; 95 % CI = 2.29-3.98). When stimulated with LPS (lipopolysaccharide) or
Pam3Cys, peripheral mononuclear cells of healthy carriers of the rs744166 GG and AG genotypes expressed higher
levels of STAT3 mRNA than those carrying AA genotype (p = 0.04 for both). The nuclear expression of phosphorylated
p-STAT3 protein was significantly higher in the antral gastric tissue of carriers of rs744166 GG genotype than in carriers
of AG and AA genotypes.
Conclusions: Our study provides evidence that STAT3 rs744166 G allele and infection with CagA-positive H. pylori with
higher number of EPIYA-C segments are independent risk factors for gastric cancer. The odds ratio of having gastric
cancer was greater when bacterium and host high risk genotypes were combined.
Keywords: Gastric cancer, STAT3 gene polymorphism, STAT3 rs744166, Helicobacter pylori, CagA, EPIYA-C segments
Background
Gastric cancer is the third leading cause of cancer-
related death in the world and one of the most common
malignancies [1] especially in developing countries
where the prevalence of Helicobacter pylori remains
high.
H. pylori infection leads to a persistent chronic gastric
inflammation by inducing the expression of inflamma-
tory cytokines that play an important role in the devel-
opment of gastric cancer.
Polymorphisms in genes encoding pro-inflammatory
cytokines have shown to increase the risk of gastric can-
cer, specifically interleukin-1β (IL1B-511/31, interleukin-
1 receptor antagonist (IL1RN*2), and tumour necrosis
factor A (TNFA-308) [2–6]. However, gastric cancer is a
multifactorial disease and several genetic factors might
be involved in the pathogenesis of the tumour.
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There are evidences that signal transducer and activator
of transcription protein 3 (STAT3) is implicated in the
development and progression of cancer and plays a role in
inducing neoplastic transformation. STAT3 participates in
a series of tumourigenic processes including cell prolifera-
tion, cell survival, anti-apoptosis, angiogenesis, immune
evasion and inflammation [7]. STAT3 is constitutively ac-
tivated in several human cancers including skin, head and
neck, ovarian, breast, colon, prostate and gastric cancer
[8–14]. The mechanism of STAT3 activation relies on the
stimulation by interleukin-6 (IL-6) cytokine family, in par-
ticular IL-6 and IL-11 and JAK (janus kinase)/STAT3-SHP
(tyrosine phosphatase)-2/ERK (extracellular-signal-regu-
lated kinases)1/2 signalling pathways emanating from the
signal transducer glycoprotein (gp)130 [15, 16]. SHP-2 is a
feedback inhibitor of JAK/STAT3 signalling. Indeed,
higher expression of SHP-2 by gain-of-function in mutant
mouse results in reduced phosphorylation of STAT3 [17].
Otherwise, increased STAT3 secretion is observed in
knock-in mice harbouring mutation abrogating SHP-2/
ERK1/2. Notably, these knock-in mice develop gastric
tumour [18–20].
The SNP (single nucleotide polymorphism) rs744166
in the intron 2 of STAT3, located on chromosome
17q21, has recently been associated with gastric cancer
in a Chinese population [21], as well as colorectal cancer
in American population of European origin [22] and
non-small-cell lung cancer in a Chinese population [23].
Associations between other STAT3 polymorphisms and
solid tumours have also been demonstrated [24, 25].
In addition to host factors, H. pylori virulent factors
increase the risk of gastric cancer, notably the cytotoxin-
associated antigen (CagA) encoded by the cagA gene (cy-
totoxin-associated gene A). Patients infected with CagA-
positive H. pylori strains either possessing EPIYA-D or
higher number of EPIYA-C segments are at increased risk
of gastric cancer [6, 26–30]. CagA is injected into gastric
epithelial cells, via bacterial type-IV secretion system,
where it undergoes tyrosine phosphorylation at specific
carboxi-terminal region comprising a variable number of
EPIYA (Glu-Pro-Ile-Tyr-Ala) segments. Four distinct
EPIYA segments designated EPIYA-A, B, C and D have
been described according to different amino acids flanking
each EPIYA motif. H. pylori strains circulating in Western
countries possess EPIYA-A and EPIYA-B that are followed
by 0-3 EPIYA-C segments, whereas H. pylori strains from
East Asian countries possess EPIYA-A, EPIYA-B and
EPIYA-D sites. Phosphorylated EPIYA-C or EPIYA-D
motif acts as a specific binding site that interacts with
SH2 domain-containing SHP-2 abnormally triggering the
SHP-2/mitogen-activated protein kinases (MAPK)/ERK1/
2-JAK/STAT3 pathways. It is worth mentioning that CagA
possessing EPIYA-D or higher number of EPIYA-C seg-
ments binds more robustly to SHP-2 [31].
Taking these considerations together and the fact that
to date there are no studies evaluating the STAT3 poly-
morphism and risk of gastric cancer in Western popula-
tions; we assessed the STAT3 polymorphism and CagA
status as well as EPIYA-C pattern of H. pylori strains
and risk of gastric cancer.
Therefore, the data were analyzed in logistic regression
models in order to identify variables independently
associated with increased risk of gastric cancer. We also
evaluated whether the polymorphism might be func-
tional by assessing the ability of peripheral blood mono-
nuclear cells (PBMCs) from healthy volunteer carriers
and non carriers of the polymorphic allele to express
STAT3 mRNA. Finally, we evaluated the nuclear expression
of phosphorylated (p)-STAT3 protein in the gastric mucosa
of gastritis patients according to the STAT3 genotypes.
Methods
This study was approved by the Ethics Committees of
Universidade Federal de Minas Gerais (UFMG ETIC
018/00) and Comissão Nacional de Ética (CONEP 096/
02) and written informed consent was obtained from all
subjects.
In total, 1048 subjects were included: 275H. pylori-
positive patients with chronic gastritis, 232H. pylori-
positive patients with distal gastric carcinoma and 541
voluntary healthy blood donors (68.4 %H. pylori-posi-
tive). The patients were selected among those who
underwent endoscopy for the evaluation of symptoms
related to the upper gastrointestinal tract or underwent
gastric surgery to remove gastric carcinoma at University
Hospital/UFMG and Luxemburgo Hospital in Belo Hori-
zonte, Brazil. The blood donors were from Fundação
Hemominas, Minas Gerais, Brazil.
Most of the included individuals (>80 %) were of low
socioeconomic level with similar cultural habits and all
were native of Minas Gerais state with the same ethnic
background, approximately 33 % of Portuguese, 33 % of
Amerindians and 33 % of African ancestry, homoge-
neously present in each individual [32].
In the gastritis patients, endoscopic biopsy samples of
the antral and oxyntic gastric mucosa were obtained for
histological and microbiological studies (culture, urease
test and PCR for H. pylori specific genes) to determine H.
pylori status. Antral and oxyntic biopsy specimens were
routinely processed and histological sections were stained
with carbolfuchsin [6] for H. pylori investigation and
hematoxyllin and eosin for histological evaluation accord-
ing to the updated Sydney System [33]. Mononuclear
(MN) and polymorphonuclear (PMN) cell infiltrations
were graded as absent (0), mild (1), moderate (2), or
marked (3). In the gastric cancer patients, the fragments
for the analyses of the presence of H. pylori were obtained
from the stomach removed by gastrectomy within one
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hour of resection. The patients were also submitted to the
13C-urea breath test imediatly before endoscopy to deter-
mine H. pylori status. The patients were considered to be
H. pylori positive when the culture was positive or when
two among the other tests were positive.
Amplification of the ureA and cagA genes
All isolates were tested for the presence of specific H.
pylori ureA gene [34]. The set of primers used and the
reaction conditions are described in Table 1. The stand-
ard Tx30a H. pylori strain was used as a positive control,
and an Escherichia coli strain and distilled water were
both used as negative controls.
In the patients, the cagA gene was amplified by means
of two previously described primer pairs [35, 36]. A H.
pylori strain from our collection (1010-95), known to be
cagA-positive, was used as a positive control, and Tx30a
H. pylori strain lacking cagA and distilled water were
both used as negative controls. The primers used and
the reaction conditions are described in Table 1. The H.
pylori strains were considered to be cagA-positive when
at least one of the two reactions was positive.
Amplification of the cagA EPIYA region
For the PCR amplification of the 3’ variable region of
the cagA gene that contains the EPIYA sequences, 20 to
100 ng of DNA were added to 1 % Taq DNA polymerase
buffer solution (KCl 50 mM and Tris-HCl 10 mM),
1.5 mM MgCl2, 100 μM of each deoxynucleotide, 1.0 U
Platinum Taq DNA polymerase (Invitrogen, São Paulo,
Brazil), and 10 pmol of each primer, for a total solution
volume of 20 μL. The primers used were previously
described by Yamaoka et al. [37] and are listed in Table 1.
The amplified products were electrophoresed in 1.5 %
agarose gel that was stained with ethidium bromide, and
analyzed in an ultraviolet light transilluminator. The
reaction yielded products of 500 to 850 bp according to
the number of EPIYA-C segments.
To confirm the results, the 3’ variable region of the
cagA gene was sequenced. Briefly PCR products were
purified with the Wizard SV Gel and PCR Clean-Up
System (Promega, Madison, MI) according to the
manufacturer’s recommendations. Purified products
were sequenced using a BigDye® Terminator v3.1
Cycle Sequencing Kit in an ABI 3130 Genetic
Analyzer (Applied Biosystems, Foster City, CA). The
sequences obtained were aligned using the CAP3 Se-
quence Assembly Program (available from: http://pbi-
l.univ-lyon1.fr/cap3.php). After alignment, nucleotide
sequences were transformed into amino acid se-
quences using the Blastx program (available from:
http://blast.ncbi.nlm.nih.gov/Blast.cgi) and compared
to sequences deposited into the GenBank (http://
www.ncbi.nlm.nih.gov/Genbank/).
H. pylori and CagA Status in the blood donors
In the blood donors, H. pylori status was investigated by
using a commercial ELISA kit (Cobas Core anti-H. pyl-
ori, EIA Roche, Basel, Switzerland), which was previously
validated for the Brazilian population being 95.4 %
sensitive and 100 % specific [38]. CagA status was
investigated by serology using a commercial ELISA kit
(Helicobacter pylori p120 CagA; Viva Diagnostika,
Hürth, Germany), which was also previously validated
for the Brazilian population being 97.4 % sensitive and
88.9 % specific [39].
STAT3 SNP rs744166 polymorphism
The STAT3 single nucleotide polymorphism (SNP)
rs744166 was chosen to be investigated because in gen-
ome wide studies the G allele was shown to be a pro-
tector factor for inflammatory bowel disease [26], which
Table 1 Primer pairs and conditions used in the PCR to detect H. pylori genes (ureA, cagA and 3’ variable region of the cagA gene
that contains EPIYA sequences) and in qRT-PCR to genotype STAT3 rs744166 and to evaluate STAT3 mRNA expression




ureA F: GCCAATGGTAAATTAGTT 95 °C - 5 min.; 34 cycles (94 °C 1 min., 45 °C - 1 min. and
72 °C - 1 min.) and 72 °C - 5 min.
411 34
R: CTCCTTAATTGTTTTTAC
cagA F:CTGCAAAAGATTGTTTGCGAGA 95 °C - 5 min, 34 cycles (95 °C 1 min, 50 °C-1 min and
72 °C-1 min) and 72 °C - 15 min
400 35
R:AGACGGTTTGTTAGAAAACGTC
cagA F:GATAACAGGCAAGCTTTTGAGG 95 °C - 5 min, 38 cycles (94 °C 1 min, 55 °C - 1 min and





F: ACCCTAGTCGGTAATGGGTTA 95 °C - 5 min, 35 cycles (95 °C 1 min, 50 °C-1 min and
72 °C-1 min.) and 72 °C - 7 min






60 °C - 1 min., 95 °C - 10 min., 50 cycles (95 °C - 15 s.,
50 °C - 90 s.) and 60 °C - 1 min.
70
Bp, base pairs; a, Applied Biosystem, HS00374280-m1
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might be attributed to a higher production of STAT3,
well known as protector of intestinal mucosa, but associ-
ated with gastric cancer in animal models [18–20].
The SNP rs744166 in the intron 2 of STAT3, located
on chromosome 17q21, was analyzed in DNA extracted
from leukocytes with the QIAamp DNA mini kit (QIA-
gen) by pre-designed Taqman SNP genotyping assay on
ABI7500 real time PCR system (Applied Biosystems,
Foster City, CA). The primer used and the reaction con-
ditions are described in Table 1.
in vitro stimulation of STAT3
In order to evaluate the effect of the STAT3 rs744166
different genotypes on the mRNA expression, we used
PBMCs from nine healthy subjects (three AA, three AG
and three GG) of the laboratory team who were H.
pylori negative, as determined by 13C-urea breath test.
Blood samples were obtained from each subject after 8-h
fast in five different days and were independently
assayed. PBMCs were freshly isolated using Ficoll-Paque
Plus (Amersham Biosciences, GE Healthcare, São Paulo,
Brazil) and 9 x 105 cells were seeded in triplicate in 24
well plates containing RPMI 1640 supplemented with
10 % fetal bovine serum, 100 U/mL penicillin and
100 μg/mL streptomycin in 5 % CO2, 95 % humidity at
37 °C for 24 h. Thereafter, PBMCs were stimulated with
LPS, an agonist of toll-like-receptor-4 (TLR-4), 100 ng/
mL from Escherichia coli 055:B5 (Sigma, St Louis, MO)
or Pam3Cys, an agonist of TLR-2, 100 ng/mL (EMC
Microcollections GmbH, Tuebingen, Germany) both di-
luted in 500 μL RPMI 1640 and incubated in 5 % CO2,
95 % humidity at 37 °C for 6 h. Unstimulated cells were
used as a negative control. According to an initial proto-
col time course experiment, six hours proved to be an
ideal time point to detect STAT3 expression after stimu-
lation with both LPS and Pam3Cys.
STAT3 RNA extraction
Total RNA was purified by using RNeasy Mini Kit (QIA-
gen). The extracted RNA was then treated with RQ1
RNase-free DNase (Promega, São Paulo, Brazil). The
RNA concentration was determined by spectrophotom-
etry using NanoDrop 2000 (Thermo Scientific, Wilming-
ton, NC). One hundred nanograms of RNA were reverse
transcribed to cDNA using a High Capacity cDNA (Ap-
plied Biosystem). A cDNA synthesis reaction including
all components except the reverse transcriptase was sub-
sequntly used as control for quantitative real time PCR
(qRT-PCR).
Relative quantification of the STAT3 transcripts
The STAT3 calibrator was purified cDNA isolated from
PBMCs containing STAT3 sequence. The remaining cali-
brators were made by a serial two-fold dilution (20.0 ng/
μL - 1,280.0 ng/μL) and tested in triplicate to determine
the most effective PCR amplification conditions. The
calibration curve produced r2 value of 0.99. The STAT3
mRNA expression was analyzed by using Taqman
primers and probe (Applied Biosystems). The qRT-PCR
was performed with thermal cycling conditions of 50 °C-
2 min, 95 °C-10 min, 50 cycles of 95 °C-15 s and, 60 °C-
1.5 min. Distilled water was also used as a negative
control.
Relative quantification of the STAT3 transcripts was
determined by means of algebraic calculation using the
method 2-ΔΔCt [40], normalized to the glyceraldheyde 3-
phosphate dehydrogenase.
Immunohistochemistry
Because it is known that expression of STAT3 in
tumour tissue depends on the stage of the tumour
[41, 42], the p-STAT3 nuclear expression was assessed
in formalin-fixed paraffin-embedded sections of the
antral and corpus mucosa of gastritis patients har-
bouring rs744166 AA, AG and GG genotypes, eight
in each group, who were randomly selected, by con-
ventional immunohistochemistry. To retrieve antige-
nicity, the sections were placed in 10 mmol/L citrate
buffer solution, pH 6.0, and heated in a microwave
for 12 min. Samples were then treated with 3 %
hydrogen peroxide-metanol for 12 min to block en-
dogenous peroxidase and, rinsed with distilled water.
The assay was performed using as primary antibody
1:50 diluted rabbit anti-human phospho-STAT3
(pTyr-705) IgG (Sigma, Cambridge, UK) with modifi-
cations including incubation with Novocastra Post
Primary Block for 30 min and with NovoLink poly-
mer for 30 min (Novocastra Laboratories Ltd, São
Paulo, Brazil). Sections were counterstained with
Meyer’s hematoxycillin and then mounted. Negative
controls were carried out by omission of the primary
antibody. Known immunostaining positive slides were
used as positive controls. The gastric epithelial cells
with the nucleus stained in brown were considered
positive for p-STAT3. The number of p-STAT3-positive
cells (proportional to the number of all cells) was
evaluated in 20 representative visual fields at a magni-
fication of 400X in an Olympus CX41RF microscope.
Slides were examined by two independent observers
who were blinded to the other results. The percentage
of positive cells for p-STAT3 was classified as 0 (none),
1 (≤50 %), 2 (50 to 90 %), and 3 (> 90 %) and staining
intensity was graded in three step scale, as follows:
1 (low), 2 (medium) and 3 (high) intensity.
Statistical analysis
The associations of the STAT3 genotypes with the number
of EPIYA-C segments and gender were evaluated by the χ2
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test with Yates’ correction and the mean age by the Stu-
dent’s t test or ANOVA and scores by the Kruskal-Wallis
test. Regarding to STAT3 mRNA expression, scores of
nuclear p-STAT3 in the gastric cells and the degree of
gastric inflammation, the differences between the groups
were evaluated by the two-tailed Mann-Whitney U-test.
p values ≤ 0.05 were considered as significant. The associa-
tions of the variables including the rs744166 STAT3 geno-
types (treated as variables having 3 values with 0 meaning
the AA genotype, 1 the carrier of one G allele and 2 the
GG genotype), CagA status, CagA EPIYA-C patterns, age
and gender were investigated in logistic regression models
by comparing gastric cancer patients with blood donors or
gastritis patients (dependent variable). Association between
the polymorphism and H. pylori status was also evaluated
in a logistic regression model in the group of blood donors.
Finally, in other model, we investigated whether the com-
bined score of the number of EPIYA-C segments and
STAT3 polymorphism increased the risk for gastric cancer.
All variables with p values ≤ 0.25 were included in the
multivariate analysis. Odds ratio (OR) and 95 % confidence
interval (CI) were used as an estimate of the risk. The
Hosmer-Lemeshow goodness-of-fit test was used to evalu-
ate the fit of the model [43].
Data were analyzed with SPSS, version 17 (SPSS Inc.,
Chicago, IL).
Results
Demographic data and rs744166 STAT3 polymorphism
The characteristics of the population are listed in Tables 2
and 3.
In the blood donors (Table 2), H. pylori infection was
more frequently observed in males than in females (p =
0.02; OR = 1.65; 95 % CI = 1.08 – 2.54), but, when the data
were adjusted for the socio-economical level, the associ-
ation disappeared (p < 0.001; OR = 0.53; 95 % CI = 0.40 –
0.70 for socio-economical level and p = 0.12 for gender).
The CagA positivity (p = 0.93; OR = 0.99; 95 % CI = 0.58 –
1.68) and the mean age (p = 0.85) did not differ when
males and females were compared (Table 2). Also, the
frequency of STAT3 AA, AG and GG genotypes did not
differ between males and females (χ2 = 1.38, 2 degrees of
freedom, p = 0.50) and between H. pylori-positive and
-negative status (χ2 = 0.73, 2 degrees of freedom, p = 0.69).
In the group of gastritis, the distribution of STAT3 geno-
types was not different in respect to the gender (χ2 = 3.05,
2 degrees of freedom p = 0.22) and cagA status (χ2 = 3.91,
2 degrees of freedom, p = 0.14), but a tendency of associ-
ation was observed between the distribution of EPIYA-C
segments and STAT3 genotypes (χ2 = 4.73, 2 degrees of free-
dom, p = 0.09), the infection by strains with EPIYA-CC or
EPIYA-CCC being less frequent in the GG genotype carriers
(Table 3). In respect to the EPIYA pattern, neither difference
in the mean age (p = 0.65) nor in the gender (χ2 = 0.25,
2 degrees of freedom, p = 0.88) was observed (Table 4).
In the gastric cancer patients, there was no significant
difference in the distribution of the STAT3 genotypes
and the number of EPIYA-C segments (p = 0.16; Kruskal
Wallis test) and cagA status (χ2 = 2.73, 2 degrees of free-
dom, p = 0.26) (Table 3). The gender neither associated
with the STAT3 genotypes (χ2 = 1.03, 2 degrees of freedom
p = 0.60) nor with the number of EPIYA-C segments
(χ2 = 0.03, 2 degrees of freedom, p = 0.98), (Table 4).
Infection by strains with higher number of EPIYA-C
segments increased with increasing age (p = 0.004).
Comparisons between the groups
No significant difference was observed between the group
of gastritis patients and blood donors regarding to the
STAT3 genotype distribution (p = 0.75; OR = 1.05; 95 %
CI = 0.76-1.45) and CagA status (p = 0.22; OR = 1.19; 95 %
CI = 0.76-1.45).
Table 2 Distribution of the STAT3 rs744166 genotypes according to the gender, mean age, H. pylori status and CagA status in blood
donors (n = 541)
Gender STAT3 genotypes
Female Male AA AG GG Total
n (%) n (%) n (%) n (%) n (%) n (%)
Female 132 (24.4) - 39 (29.5) 63 (47.8) 30 (22.7) 132 (100)
Male - 409 (75.6) 142 (34.7) 187 (45.7) 80 (19.6) 409 (100)
total - - 181 (33.5) 250 (46.2) 110 (20.3) 541 (100)
Mean age in yrs (SD) 33.6 (9.9) 33.8 (9.6) 34.6 (10.3) 33.6 (9.8) 32.9 (9.8) 33.8 (10.0)
Range yrs 18 - 59 18 - 65 18 - 65 18 - 64 19 - 59 18 - 65
Hp -ve 53 (40.2) 118 (28.9) 53 (29.3) 81 (47.4) 37 (21.6) 171 (31.6)
Hp +ve 79 (59.8) 291 (71.1) 128 (34.6) 169 (45.7) 73 (19.7) 370 (68.4)
CagA -ve 34 (43.0) 126 (43.3) 51 (31.9) 77 (48.1) 32 (20.0) 160 (43.3)
CagA +ve 45 (57.0) 165 (56.7) 73 (34.8) 95 (45.2) 42 (20.0) 210 (56.7)
n, number; SD, standard deviation; yrs, years; Hp, Helicobacter pylori; -ve, negative; +ve, positive
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By comparing the blood donors with the patients with
gastric cancer (Table 2 and Table 3), a significant difference
was observed in the frequency of CagA positive status
(p < 0.001; OR= 8.54; 95 % CI = 4.99 – 14.76) and in the
distribution of the STAT3 genotypes (χ2 = 10.86, 2 degrees
of freedom, p= 0.004). By stratifying the gender, in respect
to the STAT3 genotypes, the association remained for male
gender (χ2 = 7.54, 2 degrees of freedom p= 0.02), but not for
female gender (χ2 = 2.57, 2 degrees of freedom, p= 0.28).
When the gastritis patients were compared with the
gastric cancer patients, in the carriers of the rs744166
AA genotype, the frequency of infection with CagA
strains with one EPIYA-C segment was significantly
higher in the former (p = 0.01; OR = 2.68; 95 % CI =
1.17 – 6.28). Otherwise, in the carriers of AG (p =
0.002; OR = 3.27; 95 % CI = 1.42 – 7.67) or GG (p = 0.01;
OR = 4.2; 95 % CI = 1.32 – 14.20) genotypes, infection
with strains with two or three EPIYA-C segments were
more frequently observed in the gastric cancer than in the
gastritis patients (AB was not included in the analysis and
ABCC and ABCCC segments were analysed together in
all analyses) (Table 3).
Infection by strains with higher numbers of EPIYA-C
segments was more frequently observed in the gastric
cancer than in the gastritis patients: females (p < 0.001;
OR = 3.49; 95 % CI = 1.75 – 6.97) and males (p = 0.007;
OR 2.68; 95 % CI = 1.23 – 5.93) (Table 4).
The number of EPIYA-C segments was positively asso-
ciated with the mean age of the patients with gastric
cancer (p = 0.004), but not with the gender (p = 0.99)
(Table 4). In the group with gastritis, the number of
EPIYA-C segments neither associated with mean age
nor with gender (p > 0.64) (Table 4).
Association between STAT3 rs744166 genotypes and
gastric cancer
The alleles were in Hardy-Weinberg equilibrium in the
controls (p = 0.19).
In the blood donors, a logistic regression demonstrated
that the STAT3 genotypes were not associated with H.
pylori infection, even including the age and gender in the
model (p = 0.66; OR = 0.94; 95 % CI = 0.73 – 1.22).
Compared with blood donors, the rs744166 poly-
morphic G allele, CagA-positive status, age and gender
were independently associated with gastric cancer
(Table 5).
Next, we compared gastric carcinoma patients with
those with gastritis in order to evaluate the number of
EPIYA-C segments as a predictor of gastric cancer as
well as the co-participation of the bacterial EPIYA-C
segments and STAT3 polymorphism in the risk of the
disease. The logistic regression analysis showed that the
rs744166 polymorphism and higher number of EPIYA-C
segments were independently associated with gastric
Table 4 Distribution of the EPIYA-C patterns according to the
gender and mean age, in patients with gastritis and gastric
cancer
Disease EPIYA pattern
AB ABC ABCC ABCCC
n (%) n (%) n (%) n (%)
Gastritis (n = 275)
Female 2 (1.7) 93 (80.2) 18 (18.1) 3 (2.6)
Male 2 (3.4) 44 (75.9) 10 (19.5) 2 (3.5)
Mean age in yrs (SD) 44.3 (25.0) 54.7(16.9) 50.6 (15.1) 52.0 (11.0)
Range 27 - 73 18 - 86 27 - 73 39 - 63
Cancer (n = 232)
Female 1 (1.2) 47 (56.7) 29 (42.1) 6 (7.2)
Male 2 (1.5) 74 (56.9) 44 (41.6) 10 (7.7)
Mean age in yrs (SD) 56.5 (3.5) 60.2 (14.4) 64.4 (13.2) 70.0 (9.7)
Range 54 - 59 28 - 89 33 - 92 55 - 85
n, number; SD, standard deviation; yrs, years
Table 3 Distribution of the STAT3 rs744166 genotypes
according to the gender, mean age, CagA status and EPIYA-C
patterns in patients with gastritis and gastric cancer
Disease STAT3 genotypes
AA AG GG Total
n (%) n (%) n (%) n (%)
Gastritis (n = 275)
Female 61 (33.7) 78 (43.1) 42 (23.2) 181 (65.8)
Male 27 (28.7) 36 (38.3) 31 (33.0) 94 (34.2)
Mean age in yrs (SD) 49.6 (17.1) 53.9 (18.6) 58.6 (15.3) 53.8 (17.6)
cagA -ve 26 (25.7) 49 (48.5) 26 (25.7) 101 (36.7)
cagA +ve 62 (35.6) 65 (37.4) 47 (27.0) 174 (62.3)
EPIYA-AB 1 (25.5) 1 (25.5) 2 (50.0) 4 (2.3)
EPIYA-ABC 44(32.1) 53 (38.7) 40 (29.2) 137 (78.7)
EPIYA-ABCC 15 (53.6) 8 (28.6) 5 (17.8) 28 (16.1)
EPIYA-ABCCC 2 (40.0) 3 (60.0) 0 5 (2.9)
Gastric cancer (n = 232)
Female 19 (21.8) 41 (47.1) 27 (31.0) 87 (37.5)
Male 40 (27.6) 61 (42.1) 44 (30.3) 145 (62.5)
Mean age in yrs (SD) 63.4 (13.3) 61.5 (12.9) 61.7 (13.6) 62.0 (13.2)
cagA -ve 2 (10.5) 11 (57.9) 6 (31.6) 19 (8.2)
cagA +ve 57 (26.8) 91 (42.7) 65 (30.5) 213 (91.8)
EPIYA- AB 0 2 (66.7) 1 (33.3) 3 (1.4)
EPIYA-ABC 28 (23.1) 53 (43.8) 40 (33.1) 121 (56.8)
EPIYA-ABCC 22 (30.1) 30 (41.1) 21 (28.8) 73 (34.3)
EPIYA-ABCCC 7 (43.8) 6 (37.5) 3 (18.7) 16 (7.5)
n, number; SD, standard deviation; yrs, years. -ve, negative; +ve, positive
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cancer (Table 6). Harbouring STAT3 polymorphism plus
infection with CagA strains possessing higher number of
EPIYA-C segments was more strongly associated with
gastric cancer (Table 6).
STAT3 rs744166 polymorphism and microscopic aspects
of the gastric mucosa
Results of previous studies have shown that infection
with H. pylori CagA-positive strains are associated with
more prominent gastric inflammation and infection with
CagA strains possessing higher number of EPIYA-C seg-
ments are associated with pre-malignant gastric lesions.
Thus to avoid interference of those variables, in the
group of patients with gastritis infected with CagA-
negative strains we analyzed the association between
STAT3 and gastritis by treating rs744166 genotypes as
dichotomous variables: AA = 0 and AG +GG = 1. The
presence of G allele was associated with higher degree of
mononuclear cells in the corpus mucosa (median = 1,
range, 0-1 vs. median = 2, range, 1-3; p = 0.01).
Association between rs744166 polymorphism and in vitro
expression of STAT3
When stimulated with LPS or Pam3Cys, PBMCs of the
healthy carriers of the GG genotype expressed signifi-
cantly higher amounts of STAT3 mRNA than carriers of
the AG or AA genotype (Fig. 1).
Expression of p-STAT3 protein according to the STAT3
genotypes
Figure 2 shows nuclear localization of p-STAT3 in the
antral glandular cells and stroma cells of carriers of AA
and GG STAT3 rs744166 genotypes. The percentage of
p-STAT3 expression was significantly higher in the nuclei
of the antral glandular cells (p = 0.005 and p = 0.003) and
in the gastric stroma cells (p = 0.01 and p = 0.007) of the
patients carrying the rs744166 GG genotype than in those
carrying AG or AA genotype, respectively, but no differ-
ences were observed between the genotypes AA and AG
(p ≥ 0.49) (Fig. 3).
Discussion
To the best of our knowledge, this is the first study to
demonstrate that STAT3 rs744166 G allele is associated
with increased risk of gastric cancer in a Western popu-
lation. Conversely, the results of the study in a Chinese
population [21] showed that G allele was associated with
a decreased risk of gastric cancer, which may be ex-
plained by differences in the role of host polymorphisms
and risk of gastric cancer between Western and Eastern
populations including polymorphism in genes coding
IL1B-511 and IL1RN*2 [1–6, 44].
There are growing evidences suggesting that STAT3 has
a crucial role in carcinogenesis. STAT3 regulates expres-
sion of several genes involved in a variety of cellular re-
sponses including proliferation, differentiation, apoptosis
Table 5 Host and bacterium variables associated with gastric
cancer (n = 232) in comparison with H. pylori-positive blood
donors (n = 370)
Covariate Univariate analysis Multivariate analysis
p OR 95 % CI p
Age < 0.001 1.20 1.16 - 1.23 < 0.001
Gender < 0.001 2.99 1.48 - 6 0.002
rs744166 0.002 1.76 1.14 - 2.70 0.01
CagA +ve < 0.001 12.80 5.48 - 29.86 < 0.001
The Hosmer-Lemeshow test showed good fit (10 steps; 8 degrees of freedom;
p = 0.20). rs744166 genotype was treated as categorical variables having 3
values with 0 meaning the AA genotype, 1 the carrier of one G allele and 2
the GG genotype, +ve, positive
Table 6 Host and bacterium variables associated with gastric cancer (n = 213) in comparison with gastritis (n = 174) in patients
infected by H. pylori cagA-positive strains
Covariates Univariate analysis Multivariate analysis
p OR 95 % CI p
First modela
Age < 0.001 1.04 1.02 - 1.05 < 0.001
Gender < 0.001 3.58 2.10 - 6.09 < 0.001
rs744166 0.007 1.64 1.16 - 2.31 0.005
EPIYA-C number < 0.001 2.28 1.41 - 3.68 0.001
Second modelb
Age < 0.001 1.05 1.05 - 1.06 < 0.001
Gender < 0.001 3.23 2.02 - 5.17 < 0.001
rs744166 plus EPIYA-C number < 0.001 3.01 2.29 - 3.97 < 0.001
The Hosmer-Lemeshow tests showed good fit for models a(10 steps, 8 degrees of freedom; p = 0.42) b(10 steps, 8 degrees of freedom; p = 0.25), OR, odds ratio; 95 %
CI: confidence interval. We constructed two models studying the loci, according to the amount of G rs744166 allele, treated as categorical variables having 3 values with
0 meaning the AA genotype, 1 the carrier of one G allele and 2 the GG genotype. In the second model the variable was obtained by the sum of the amount of STAT3 G
allele and the number of EPIYA-C segments
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and wound healing [45]. STAT3 activity supports tumour-
cell survival by up regulating expression of the anti-
apoptotic protein BCL-XL (B-cell lymphoma-2-like) and
many other proteins involved in cell proliferation and
survival including myeloid cell leukaemia 1 (MCL1), cyclin
D1 and MYCC [14, 46]. Furthermore, STAT3 selectively
induces and maintains a pro-inflammatory microenviron-
ment that further supports tumour progression.
The results of the present study are in opposite to that
observed in patients with Crohn’s disease who are more
frequently carriers of the A than the G allele [26]. There
are evidences that physiologic consequences of the mul-
tiple STAT3 actions depend on the specific cell types
involved [45]. STAT3 plays a protective role in the
intestinal mucosa as demonstrated in knockout mice
with intestinal epithelial cell-specific deletion of STAT3
that exhibit more severe induced acute colitis than the
control group with a functioning STAT3 [19, 47]. It has
been suggested that increased STAT3 signalling may
predispose to up regulation of trefoil factor family3
(TFF3) gene expression in intestinal globet cells and pro-
tection against IBD [19] and downregulates trefoil factor
family-1 (TFF1), a gastric-specific tumour suppressor,
predisposing to neoplastic transformation [48]. In fact,
mice with knock-in mutation located at Y757F on
gp130, which destroys the docking site for SOCS3 that
negatively regulates STAT3 activation, develop antral
gastric cancer [19, 20, 49]. In addition, in the present
study we observed that H. pylori-positive individuals
harbouring AG or GG genotypes had high degree of
mononuclear cells in the gastric corpus, considered a
pre malignant lesion.
Although to date, no functional role has been attrib-
uted to STAT3 rs744166 polymorphism, in this study,
the expression of STAT3 mRNA was significantly higher
in stimulated PBMCs from a group of healthy volun-
teers, carrying the GG genotype, than from those carry-
ing AG or AA genotype. Supporting these findings we
also found that the phosphorylated protein STAT3 ex-
pression was significantly higher in the gastric tissue of
patients carrying the GG genotype than in those carrying
AG or GG genotype. Based on these findings, we might
suppose that STAT3 rs744166 polymorphism is func-
tional, or is in Hardy-Weinberg disequilibrium with
other polymorphism that increases STAT3 transcription
and STAT3 secretion.
Of note, in this study we observed differences in the
risk of gastric cancer according to the gender; when gas-
tric cancer patients were compared with blood donors,
the G allele being associated with increased risk of gas-
tric cancer only in males. Otherwise, although infection
with higher number of EPIYA-C segments was associ-
ated with pre malignant lesions (data not shown) and
gastric cancer in both males and females, we found that
the odds ratio of having gastric cancer was more robust
in females (3.49 vs. 2.69). Based on these findings, one
may speculate that there are different pathways of
Fig. 1 Box plots representing mRNA STAT3 expression of five
independent measurements, performed in triplicate. The upper and
lower limits of the boxes represent the 75th and 25th percentiles,
respectively; the horizontal bar across the box indicates the median
and the end of the vertical lines indicate the minimum and
maximum data values. Quantitative real-time PCR was used to
analyze the influence of STAT3 rs744166 genotypes on the STAT3
mRNA expression before and after LPS or Pam3Cys stimulation. Gene
expression was normalized to the expression of a reference gene,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). PBMCs of
healthy H. pylori-negative subjects, as determined by 13C-urea breath
test, carrying rs744166 GG (n = 3), AG (n = 3) or AA genotypes (n = 3)
were stimulated with 100 μg/mL LPS or 100 μg/mL Pam3Cys for 6 h.
RNA was purified and STAT3 mRNA expression analyzed by qRT-PCR.
A cDNA synthesis reaction including all components except the
reverse transcriptase was subsequently used as control for
quantitative real time PCR (qRT-PCR). Distilled water was also used as
a negative control
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carcinogenesis between males and females. EPIYA-C
binds to one or two SH2 domains of SHP-2, which in
turn potentiates Ras-ERK signalling pathway that results
in oncogenic stress [50], meanwhile, STAT3 polymorph-
ism possibly activates JAK/STAT3 pathway. However, we
can not rule out that the differences observed might be
due to a bias because the number of females is smaller
than that of males in the blood donors.
When we compared gastritis and gastric cancer pa-
tients, we also demonstrated that the association was
more robust in the presence of concurrent STAT3 poly-
morphism and the infection with CagA strains with
higher number of EPIYA-C segments, highlighting the
relevance of both bacterial and host factors as predictors
of gastric cancer. Remarkably we found that in patients
with gastric cancer the rs744166 GG genotype and infec-
tion with CagA strains with higher number EPIYA-C
segments predominate.
Conclusions
In conclusion, the present study shows that STAT3
rs744166 polymorphism and infection with H. pylori
with CagA possessing higher number of EPIYA-C seg-
ments are independent risk factors for gastric cancer in
Fig. 2 Representative immunohistochemical staining showing nuclear localization of p-STAT3 in the antral glandular cells and stroma cells under
low-power (100x) and high-power (400x) magnification of carriers of AA and GG STAT3 rs744166 genotypes: a and b, mock; c and d, medium
brown-colored nuclei in the gastric stroma cells and glandular cells of a carrier of AA genotype and e and f, densely stained nuclei of 100 % of
cells, both of the gastric stroma (arrow head) and glands (arrow) in a carrier of GG genotype. The percentage of positive cells for STAT3 was
classified as 0 (none), 1 (≤ 50 %), 2 (50 to 90 %), and 3 (> 90 %) and staining intensity was graded in three step scale, as follows: 1 (low), 2
(medium) and 3 (high) intensity
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the evaluated population. Therefore, individuals with
genetic polymorphisms associated to STAT3 who are
colonized by CagA strains with higher number of
EPIYA-C segments are most likely to benefit from H.
pylori eradication aiming to prevent gastric cancer as it
has been recommended by the IARC working group on
Helicobacter pylori eradication as a strategy for prevent-
ing gastric cancer. According to the group all countries
should explore the possibility of introducing population-
based H. pylori screening and treatment programmes
especially for subpopulations that appear most likely to
benefit from interventions.
Fig. 3 Box plots representing scores of nuclear p-STAT3 expression in the antral glandular cells and stroma cells of patients with gastritis
according to the different STAT3 rs744166 gentotypes. The upper and lower limits of the boxes represent the 75th and 25th percentiles, respectively;
the horizontal bar across the box indicates the median and the end of the vertical lines indicate the minimum and maximum data values
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